Le Lézard
Classified in: Health, Covid-19 virus
Subject: MRR

Insights on the Body Fat Reduction Global Market to 2030 - New Developments and Increasing Number of Facilities Offering Fat Reduction Services Presents Opportunities


DUBLIN, Jan. 26, 2022 /PRNewswire/ -- The "Body Fat Reduction Market by Procedure Type, Gender, and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The global body fat reduction market was valued at $7,587.77 million in 2020, and is projected to reach $13,910.63 million by 2030, registering a CAGR of 7.5% from 2021 to 2030.

Body fat is commonly the accumulation of adipose tissue, a complex connective tissue with specialized roles in metabolism and endocrine function. Body fat reduction, in the context of medicine, health, or physical fitness, refers to decrease in total body mass caused by loss of fluid, body fat adipose tissue, or lean mass, notably bone mineral deposits, muscle, tendon, and other connective tissue. Body fat removal techniques are often utilized in cosmetic surgery to eliminate excess adipose tissues or fats from the body either by a surgical or a non-surgical procedure.

Higher percentage of body fat leads to weight gain in individuals and further leads to obesity. Obesity is a complicated illness characterized by excess of body fat. Obesity is more than simply an aesthetic issue. It is a medical condition that raises the chance of developing other diseases and health issues, such as heart disease, diabetes, high blood pressure, and some malignancies. Obesity in males is defined as a proportion of body fat more than 25%, with 21-25% considered borderline. Obesity is defined as having a body mass index (BMI) of greater than 33% in women. The higher the proportion of body fat, the more probable is it to develop obesity-related diseases such as cardiac diseases, hypertension, higher chances of having a stroke, and type 2 diabetes.

According to the World Health Organization (WHO), most of the world's population live in countries where overweight and obesity kills more people than underweight individuals and 39 million children under the age of 5 were overweight or obese in 2020 globally. Overweight and obesity, formerly thought to be a problem only in high-income nations, are now on the rise in low and middle income countries, particularly in metropolitan areas. In Africa, the number of overweight children under 5 has increased by nearly 24% since 2000. Almost half of the children under 5 who were overweight or obese in 2019 live in Asia.

Growth of the global body fat reduction market is majorly driven by rise in consumption of carbohydrate-based foods, packaged foods, poor eating habits, and unhealthy lifestyle among young generation as well adults thus leading to weight gain and further obesity. Furthermore, according to the World Obesity Federation if the current trends continue, it is estimated that approximately 2.7 billion adults will be overweight, over 1 billion affected by obesity, and 177 million adults severely affected by obesity by 2025. Thus, surge in obesity population is expected to boost the body fat reduction market.

The body fat reduction market is segmented on the basis of procedure type, gender, end user, and region. On the basis of procedure type, the market is categorized into surgical and non-surgical. The surgical segment is further categorized into liposuction and abdominoplasty. Moreover, the non-surgical segment is subdivided into cryolipolysis, ultrasound, and others. On the basis of gender, the market is segregated into male and female. By end user, it is fragmented into hospitals & clinics, medical spas, and others.

Key Benefits

Key Topics Covered:

CHAPTER 1: INTRODUCTION

CHAPTER 2: EXECUTIVE SUMMARY

CHAPTER 3: MARKET LANDSCAPE
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porter's five force analysis
3.4. Top player positioning, 2020
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Increasing prevalence of obesity
3.5.1.2. Growing focus on aesthetics and cosmetic surgeries
3.5.1.3. Technological advancements and rise in adoption of minimally invasive procedures
3.5.2. Restraint
3.5.2.1. High cost of procedures coupled with post treatment complications
3.5.3. Opportunity
3.5.3.1. New developments and increasing number of facilities offering fat reduction services
3.5.4. Impact analysis
3.6. COVID-19 impact analysis on the body fat reduction market

CHAPTER 4: BODY FAT REDUCTION MARKET, BY PROCEDURE
4.1. Overview
4.1.1. Market size and forecast
4.2. Surgical
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.2.4. Market size and forecast, by type
4.2.4.1. Liposuction
4.2.4.1.1. Market size and forecast
4.2.4.2. Abdominoplasty
4.2.4.2.1. Market size and forecast
4.3. Non-Surgical
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.3.4. Market size and forecast, by type
4.3.4.1. Cryolipolysis
4.3.4.1.1. Market size and forecast
4.3.4.2. Ultrasound
4.3.4.2.1. Market size and forecast
4.3.4.3. Others
4.3.4.3.1. Market size and forecast

CHAPTER 5: BODY FAT REDUCTION MARKET, BY GENDER
5.1. Overview
5.1.1. Market size and forecast
5.2. Male
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Female
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country

CHAPTER 6: BODY FAT REDUCTION MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals & clinics
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.3. Medical spas
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country
6.4. Others
6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by country

CHAPTER 7: BODY FAT REDUCTION MARKET, BY REGION

CHAPTER 8: COMPANY PROFILES
8.1. ABBVIE INC. (ALLERGAN INC.)
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. APOLLO HOSPITALS ENTERPRISE LIMITED (APOLLO COSMETIC CLINICS)
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.3. BAUSCH HEALTH COMPANIES INC. (SOLTA MEDICAL INTERNATIONAL INC.)
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.4. CANDELA MEDICAL
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.5. CUTERA INC.
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments
8.6. CYNOSURE, LLC.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Key strategic moves and developments
8.7. LUMENIS LTD.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Key strategic moves and developments
8.8. SCITON, INC.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Key strategic moves and developments
8.9. SISRAM MEDICAL LTD (ALMA LASERS LTD.)
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments
8.10. VLCC HEALTH CARE LTD.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance

For more information about this report visit https://www.researchandmarkets.com/r/n6qdfu

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716



SOURCE Research and Markets


These press releases may also interest you

at 02:08
Revenue amounted to ?498.8m (?419.3m), an increase of 18.9% with an organic growth of 14.2%.Operating profit (EBIT) was ?19.0m (?10.7m), an increase of 78.0%, representing an operating margin of 3.8% (2.6%).Net profit amounted to ?6.5m (?2.1m), which...

at 02:00
Nebula Energy and Gogoro Inc , a global technology leader in battery-swapping ecosystems that enable sustainable mobility solutions for cities,...

25 avr 2024
Ankur Daga, CEO of Angara, a leading online DTC fine jewelry retail brand, has been named the winner of a Gold Stevie® Award in the Best Entrepreneur - Retail category in the 22nd Annual American Business Awards®. Ankur Daga Wins Gold...

25 avr 2024
The report titled "Identity Governance & Administration Market by Component (Services, Solution), Modules (Access Certification & Compliance Control, Access Management, Identity Lifecycle Management), Organization Size, Deployment, Vertical - Global...

25 avr 2024
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class Period") of the important June 11, 2024 lead...

25 avr 2024
Results  For the year ended January 31, 2024, the Company's revenues decreased by $139,027,000 to $578,945,000 compared to $717,972,000 recorded for the year ended January 31, 2023, a decrease of 19.4%. This decrease is mainly explained by the...



News published on and distributed by: